Minerva Neurosciences Stock (NASDAQ: NERV) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 19.62K |
Day Range | - - - |
52 Wk Range | 2.26 - 13.49 |
Market Cap | $19.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 0.28% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Monopar Therapeutics (NASDAQ:MNPR), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
Minerva Neurosciences has a consensus price target of $5.00.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.82 last updated September 20, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.